Aarkstore - Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 PowerPoint presentation | free to download - id: 7227ea-ZjAwZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Description:

“Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014”, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:13

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014


1
Aarkstore - Chemotherapy Induced Neutropenia -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary
  • Chemotherapy Induced Neutropenia - Pipeline
    Review, H2 2014, provides an
  • overview of the Chemotherapy Induced Neutropenias
    therapeutic pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Chemotherapy Induced Neutropenia,
    complete with comparative analysis at
  • various stages, therapeutics assessment by drug
    target, mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
  • Chemotherapy Induced Neutropenia and special
    features on late-stage and discontinued
  • projects.

www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Chemotherapy
    Induced Neutropenia- The report reviews key
    pipeline products under drug profile section
    which includes, product description, MoA and RD
    brief, licensing and collaboration details
    other developmental activities - The report
    reviews key players involved in the therapeutics
    development for Chemotherapy Induced Neutropenia
    and enlists all their major and minor projects-
    The report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Chemotherapy Induced Neutropenia products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects

www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Chemotherapy Induced Neutropenia- Plan
    mergers and acquisitions effectively by
    identifying key players of the most promising
    pipeline- Devise corrective measures for
    pipeline projects by understanding Chemotherapy
    Induced Neutropenia pipeline depth and focus of
    Indication therapeutics- Develop and design
    in-licensing and out-licensing strategies by
    identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and Scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

www.aarkstore.com
5
Table of Contents
  • Introduction 9Global Markets Direct
    Report Coverage 9Chemotherapy Induced
    Neutropenia Overview 10Therapeutics Development
    11Pipeline Products for Chemotherapy Induced
    Neutropenia - Overview 11Pipeline Products for
    Chemotherapy Induced Neutropenia - Comparative
    Analysis 12Chemotherapy Induced Neutropenia -
    Therapeutics under Development by Companies
    13Chemotherapy Induced Neutropenia -
    Therapeutics under Investigation by
    Universities/Institutes 16Chemotherapy Induced
    Neutropenia - Pipeline Products Glance 17Late
    Stage Products 17

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Chemotherapy Induced Neutropenia, H2 2014
    11Number of Products under Development for
    Chemotherapy Induced Neutropenia - Comparative
    Analysis, H2 2014 12Number of Products under
    Development by Companies, H2 2014 14Number of
    Products under Development by Companies, H2 2014
    (Contd..1) 15Number of Products under
    Investigation by Universities/Institutes, H2 2014
    16Comparative Analysis by Late Stage
    Development, H2 2014 17Comparative Analysis by
    Clinical Stage Development, H2 2014
    18Comparative Analysis by Early Stage
    Development, H2 2014 19Comparative Analysis by
    Unknown Stage Development, H2 2014 20Products
    under Development by Companies, H2 2014 21

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Chemotherapy Induced Neutropenia, H2 2014
    11Number of Products under Development for
    Chemotherapy Induced Neutropenia - Comparative
    Analysis, H2 2014 12Number of Products under
    Development by Companies, H2 2014 13Comparative
    Analysis by Late Stage Development, H2 2014
    17Comparative Analysis by Clinical Stage
    Development, H2 2014 18Comparative Analysis by
    Early Stage Products, H2 2014 19Assessment by
    Monotherapy Products, H2 2014 45Number of
    Products by Top 10 Targets, H2 2014 46Number of
    Products by Stage and Top 10 Targets, H2 2014
    46Number of Products by Top 10 Mechanism of
    Actions, H2 2014 48

www.aarkstore.com
8
Related Market Research reports
  • Blirt S.A. - Product Pipeline Review 2014
  • Auris Medical Holding AG - Product Pipeline
    Review 2014
  • Integral Molecular, Inc. - Product Pipeline
    Review 2014
  • DaVinci Biosciences, LLC - Product Pipeline
    Review 2014
  • Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports
  • TiGenix NV - Product Pipeline Review 2014
  • Egenix, Inc. - Product Pipeline Review 2014
  • SkyePharma PLC - Product Pipeline Review 2014
  • MediWound Ltd. - Product Pipeline Review 2014
  • BioTech Tools s.a. - Product Pipeline Review -
    2014

www.aarkstore.com
10
Aarkstore - Chemotherapy Induced Neutropenia -
Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com